This trial is testing a new way to fight cancer by genetically engineering patients' T cells to better target and kill their tumor cells.
1 Primary · 2 Secondary · Reporting Duration: 15 years
Experimental Treatment
27 Total Participants · 1 Treatment Group
Primary Treatment: CATCH T cells · No Placebo Group · Phase 1
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: